<?xml version="1.0" encoding="ISO-8859-1"?>
<entity-relation-data lastUpdate="2023-03-27 16:49:02" record="25804" source="Espacenet">
	<entities>
		<entity ref="Patent25804" type="Patent">
			<semanticIdentifier>brcris::2aa43182888c7f0b4a2e4744454a6ddb</semanticIdentifier>
			<semanticIdentifier>docdb::BR102018072747A2</semanticIdentifier>
			<semanticIdentifier>epodoc::BR102018072747</semanticIdentifier>
			<semanticIdentifier>docdb::BR102018072747A</semanticIdentifier>
			<semanticIdentifier>epodoc::BR20181072747</semanticIdentifier>
			<semanticIdentifier>original::102018072747</semanticIdentifier>
			<field name="urlEspacenet" value="https://worldwide.espacenet.com/patent/search?q=102018072747"/>
			<field name="identifier.lattes" value="1841833705087719"/>
			<field name="identifier.espacenet" value="102018072747"/>
			<field name="kindCode" value="A2"/>
			<field name="title.espacenet" value="formulação de uso combinado do [10]-gingerol (10g) com a doxorubicina (doxo) para o tratamento de câncer de mama triplo negativo (cmtn)"/>
			<field name="title.lattes" value="'FORMULAÇÃO DE USO COMBINADO DO [10]-GINGEROL (10G) COM A DOXORUBICINA (DOXO) PARA O TRATAMENTO DE CÂNCER DE MAMA TRIPLO NEGATIVO"/>
			<field name="depositDate" value="2018-11-05"/>
			<field name="publicationDate" value="2020-05-26"/>
			<field name="countryCode" value="BR"/>
			<field name="inventor" value="ANA CAROLINA BAPTISTA MORENO MARTIN"/>
			<field name="inventor" value="ANGELICA ELLEN GRAMINHA VERONI"/>
			<field name="inventor" value="LIANY JOHANNA LUNA DULCEY"/>
			<field name="inventor" value="MARCIA REGINA COMINETTI"/>
			<field name="inventor" value="MARINA ARAUJO NAVES"/>
			<field name="inventor" value="PAULO CEZAR VIEIRA"/>
			<field name="inventor" value="RAMON HANDERSON GOMES TELES"/>
			<field name="inventor" value="REBEKA TOMASIN"/>
			<field name="applicant" value="FUNDACAO UNIVERSIDADE FEDERAL DE SAO CARLOS"/>
			<field name="classification.ipc">
				<field name="sequence" value="1"/>
				<field name="text" value="A61P35/00AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="P"/>
				<field name="group" value="35"/>
				<field name="subgroup" value="00AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="2"/>
				<field name="text" value="A61K31/704AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="31"/>
				<field name="subgroup" value="704AI"/>
			</field>
			<field name="classification.ipc">
				<field name="sequence" value="3"/>
				<field name="text" value="A61K36/9068AI"/>
				<field name="section" value="A"/>
				<field name="class" value="61"/>
				<field name="subclass" value="K"/>
				<field name="group" value="36"/>
				<field name="subgroup" value="9068AI"/>
			</field>
			<field name="abstract.espacenet" value="formulação de uso combinado do [10]-gingerol (10g) com a doxorubicina (doxo) para o tratamento de câncer de mama triplo negativo (cmtn). nova formulação de uso combinado do [10]-gingerol (10g) com a doxorubicina (doxo) para o tratamento de câncer de mama triplo negativo (cmtn), a qual apresenta menores efeitos colaterais, sendo mais eficaz e efetiva inibindo o tamanho dos tumores primários de cmtn, bem como metástases pulmonares e ósseas e com redução dos efeitos tóxicos da quimioterapia padrão, a qual é obtida de produtos naturais que são fontes ricas em moléculas com atividades antitumorais e antimetastáticas, contendo moléculas de gingerois, presentes no gengibre, que apresentam maior atividade citotóxica em cmtn."/>
			<field name="originatesFrom" value="70976681"/>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102018072747"/>
				<field name="kind" value="A2"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Publication"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR102018072747"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="docdb"/>
				<field name="country" value="BR"/>
				<field name="number" value="102018072747"/>
				<field name="kind" value="A"/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="epodoc"/>
				<field name="country" value="BR"/>
				<field name="number" value="BR20181072747"/>
				<field name="kind" value=""/>
			</field>
			<field name="alternateIdentifier">
				<field name="status" value="Application"/>
				<field name="format" value="original"/>
				<field name="country" value=""/>
				<field name="number" value="102018072747"/>
				<field name="kind" value=""/>
			</field>
		</entity>
		<entity ref="Person17874" type="Person">
			<semanticIdentifier>lattes::1841833705087719</semanticIdentifier>
			<field name="identifier.lattes" value="1841833705087719"/>
			<field name="name" value="Liany Johanna Luna Dulcey"/>
		</entity>
		<entity ref="OrgUnit13945" type="OrgUnit">
			<semanticIdentifier>brcris::01bf8bb8899ab63c21b33a5e3d56f51c</semanticIdentifier>
			<field name="name" value="FUNDACAO UNIVERSIDADE FEDERAL DE SAO CARLOS"/>
		</entity>
	</entities>
	<relations>
		<relation fromEntityRef="Patent25804" toEntityRef="Person17874" type="Inventor"/>
		<relation fromEntityRef="Patent25804" toEntityRef="OrgUnit13945" type="Applicant"/>
	</relations>
</entity-relation-data>
